FRAX the more clinically relevant measure

In his latest Clinical Update, Gary Culliton examines recent developments in the field of osteoporosis, including diagnostic tools and issues related to glucocorticoids. Osteoporosis is a progressive, systemic skeletal disease characterised by low bone mass and micro-architectural deterioration of bone tissue. There is a consequential increase in bone fragility and susceptibility to fractures. There are changes in bone density with increasing age. Peak bone mass is reached in the 30s, according to Prof Oliver FitzGerald, Consultant Rheumatologist and National Programme Lead in Rheumatology. “Thereafter, there’s a fall in bone mass — at a more pronounced rate following menopause,” he added.…